Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ) rose sharply in today's pre-market trading.
CORXEL and LENZ Therapeutics revealed topline data from China Phase 3 Presbyopia trial of LNZ100.
LENZ Therapeutics shares jumped 18% to $31.88 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
